Asthma, Asthma Medications, and Prostate Cancer Risk

Abstract

Background: The aim of this study was to assess whether a history of asthma or the use of asthma medications is associated with prostate cancer risk.Methods: Of 16,934 men participating in the Melbourne Collaborative Cohort Study, 1,179 were diagnosed with prostate cancer during an average follow-up of 13.4 years to the end of December 2007. Information on asthma history was obtained at baseline interview. Participants were asked to bring their current medications to the study center. The names of the drugs were entered into a form and coded. Asthma medications were categorized into four groups and corresponding hazard ratios (HR) were estimated from Cox regression models adjusted for country of birth.Results: Asthma was associated with a small increase in prostate cancer risk [HR 1.25; 95% confidence interval (95% CI), 1.05-1.49]. The HRs for use of medications were 1.39 (95% CI, 1.03-1.88) for inhaled glucocorticoids, 1.71 (95% CI, 1.08-2.69) for systemic glucocorticoids, 1.36 (95% CI, 1.05-1.76) for bronchodilators, and 0.78 (95% CI, 0.45-1.35) for antihistamines. The HRs for asthma and asthma medication use changed only slightly after mutual adjustment.Conclusions: A history of asthma and the use of asthma medications, particularly systemic glucocorticoids, are associated with an increased risk of prostate cancer, although it is difficult to disentangle the effects of asthma medications from those of asthma per se.Impact: These findings, if confirmed in independent studies, might lead to the identification of new risk factors for prostate cancer. Cancer Epidemiol Biomarkers Prev; 19(9); 2318-24. ©2010 AACR.

Relationship between Allergy and Cancer: An Overview

“…Glucocorticoids used for the treatment of asthma were shown to increase cancer risk due to immunosuppressive and antiapoptotic properties [30,43]. The same active substances are present in ointments for treatment of atopic dermatitis [19].…”

Long-term study of subclinical Cushing^|^rsquo;s syndrome shows high prevalence of extra-adrenal malignancy in patients with functioning bilateral adrenal tumors

“…increased the risk of skin, bladder and prostate cancers and non-Hodgkin lymphomas [39][40][41]. Further clinical studies will be needed to clarify the relationship between systemic glucocorticoid therapy and cancer risk.…”

Correlation between long-term outcome and steroid therapy in type 1 autoimmune pancreatitis: relapse, malignancy and side effect of steroid

“…However, it has not been clarified whether patients with IgG4-RD are at high risk for developing a malignancy. CST is a risk factor to develop malignancy [7][8][9][10][11][12]. The associations between CST and malignancies in the IgG4-RD or AIP populations have not been reported to date.…”